Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/194643
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cormand Rifà, Bru | - |
dc.contributor.author | Cabana Domínguez, Judit | - |
dc.contributor.author | Forero, Diego A. | - |
dc.contributor.author | Fernàndez Castillo, Noèlia | - |
dc.date.accessioned | 2023-03-03T18:37:04Z | - |
dc.date.available | 2023-03-03T18:37:04Z | - |
dc.date.issued | 2021-05-11 | - |
dc.identifier.issn | 1552-4841 | - |
dc.identifier.uri | http://hdl.handle.net/2445/194643 | - |
dc.description.abstract | Substance use disorders (SUD) are common conditions around theworld, with important health and societal impacts, particularly inthe burden of disease (disability-adjusted life years) (Whiteford, Fer-rari, Degenhardt, Feigin, & Vos, 2015). The Global Burden of DiseaseStudy estimated the global number of cases for SUD for several sub-stances as follows: 94.8 million for alcohol, 17.2 million for amphet-amine, 15.5 million for opioids, and 13.1 million for cannabis(Whiteford, 2015). In the United States, the lifetime and 12-monthprevalences of SUD were 9.9% and 3.9%, respectively (Grantet al., 2016). In addition, polysubstance use is an important challengein the field of addiction research (Whiteford et al., 2015). | - |
dc.format.extent | 3 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Wiley-Liss | - |
dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1002/ajmg.b.32844 | - |
dc.relation.ispartof | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2021, vol. 186, num. 3, p. 125-127 | - |
dc.relation.uri | https://doi.org/10.1002/ajmg.b.32844 | - |
dc.rights | (c) Wiley-Liss, 2021 | - |
dc.source | Articles publicats en revistes (Genètica, Microbiologia i Estadística) | - |
dc.subject.classification | Genòmica | - |
dc.subject.classification | Abús de substàncies | - |
dc.subject.classification | Malalties | - |
dc.subject.other | Genomics | - |
dc.subject.other | Substance abuse | - |
dc.subject.other | Diseases | - |
dc.title | Genomics and epigenomics of substance use disorders: An introduction | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/acceptedVersion | - |
dc.identifier.idgrec | 721508 | - |
dc.date.updated | 2023-03-03T18:37:04Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Genètica, Microbiologia i Estadística) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
721508.pdf | 138.33 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.